Trials / Completed
CompletedNCT00247650
Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy
Randomized Multi-Center Study Comparing Prolonged Primary Systemic Endocrine Therapy With Letrozole Alone or in Combination With Zoledronic Acid in Early Breast Cancer (NEOadjuvant Study in CANada)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 190 (estimated)
- Sponsor
- Novartis · Industry
- Sex
- Female
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
This study is to measure the extent of tumor shrinkage when Letrozole and Zoledronic Acid are given before surgery to newly diagnosed post-menopausal women with early breast cancer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zoledronic Acid; Letrozole |
Timeline
- Start date
- 2005-09-01
- Primary completion
- 2007-03-01
- First posted
- 2005-11-02
- Last updated
- 2017-03-01
Locations
10 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT00247650. Inclusion in this directory is not an endorsement.